Regulatory affairs in an ideal world
This article was originally published in SRA
Executive Summary
Parvinder Punia takes a look at the challenges today's pharmaceutical companies face when attempting a single global development and evaluates how things might be different were a single global overseeing agency to exist. Her analysis explores how current region-specific needs are being utilized to protect individual territorial markets and how these regional differences affect the access of poverty-stricken countries to medicine.